| Pharmaceutical Information |
| Drug Name |
Streptokinase |
| Drug ID |
BADD_D02070 |
| Description |
Streptokinase, is a sterile, purified preparation of a bacterial protein elaborated by group C (beta) -hemolytic streptococci. |
| Indications and Usage |
For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae |
| Marketing Status |
Not Available |
| ATC Code |
B01AD01 |
| DrugBank ID |
DB00086
|
| KEGG ID |
D06879
|
| MeSH ID |
D013300
|
| PubChem ID |
9815560
|
| TTD Drug ID |
D04URO
|
| NDC Product Code |
Not Available |
| Synonyms |
Streptokinase | Streptase | Streptodecase | Kabikinase | Awelysin | Celiase | Distreptase | Kabivitrum | Avelizin |
|
| Chemical Information |
| Molecular Formula |
C11H19NO2 |
| CAS Registry Number |
9002-01-1 |
| SMILES |
C1CCC(CC1)C2CC(NC2)C(=O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
